| 
								Compound α-Ketoacid Tablets							
 | 
| 
								Creatine Phosphate Sodium for Injection							
 | 
| 
								Metformin Tablets							
 | 
| 
								Advanced Liposome Dosage Forms							
 | 
| 
								DAWN PHARMA							
 | 
| 
								Histroy							
 | 
| 
								Culture							
 | 
| 
								Chairman's Profile							
 | 
| 
								Introduction							
 | 
| 
								Contact Us							
 | 
| 
								2021							
 | 
| 
								2020							
 | 
| 
								2019							
 | 
| 
								2018							
 | 
| 
								2017							
 | 
| 
								2016							
 | 
| 
								2015							
 | 
| 
								2014							
 | 
| 
								2013							
 | 
| 
								 2012							
 | 
| 
								 2011							
 | 
| 
								 2010							
 | 
| 
								 2009							
 | 
| 
								 2008							
 | 
| 
								2007							
 | 
| 
								2006							
 | 
| 
								2005							
 | 
| 
								 2004							
 | 
| 
								 2003							
 | 
| 
								 2002							
 | 
| 
								 2001							
 | 
| 
								 2000							
 | 
| 
								 1998 and 1999							
 | 
| 
								Sterile Creatine Phosphate Sodium API Approved for Production							
 | 
| 
								Asia Pharma Expo Bangladesh, February 12-14 2025							
 | 
| 
								CPhI Milan Stand 16F1 from October 8-10, 2024. Welcome!							
 | 
| 
								CPhI China Stand E3P02 from June 19-21, 2024. Welcome!							
 | 
| 
								Stall 7G69 at 2023 CPhI Worldwide in Barcelona							
 | 
| 
								Stall K10 at 2023 CPhI South East Asia in Thailand							
 | 
| 
								Welcome! CPhI China Stand E4P16 from June 19-21, 2023							
 | 
| 
								Core Product: Paracetamol Tablets							
 | 
| 
								Core Product: Metformin HCl Tablets							
 | 
| 
								Paclitaxel for Injection (Albumin Bound)							
 | 
| 
								Peramivir Intermediates‘ Commercial Production Started							
 | 
| 
								Stand F.06 CPhI India Dehli 26-28 November 2019							
 | 
| 
								EU GMP of Dawn Pharma Issued							
 | 
| 
								Stand 91G04 CPhI Worldwide Frankfurt 5-7 November 2019							
 | 
| 
								CPhI China 2019 Stand No. E3P02: Welcome !							
 | 
| 
								4 Units Drive Tiancheng's New Development in 2019							
 | 
| 
								Welcome to Stand 14.0B33SSP CPhI Worldwide Madrid 9-11 October 2018							
 | 
| 
								EU GMP Good News - Dawn Pharma's Two Injectable Lines Passed Site Inspection of EU GMP							
 | 
| 
								Welcome to Stand BA37 CPhI India Mumbai 27-29 November 2017							
 | 
| 
								Welcome to Stand 90F64NEP CPhI Worldwide Franfurt Germany 24-26 October 2017							
 | 
| 
								CPhI China 2017 Stand No. E3P02: Welcome !							
 | 
| 
								SGS Audited Supplier Certificate of Hebei Tiancheng Pharma							
 | 
| 
								 Four Injection Production Lines Passed CFDA GMP Certification							
 | 
| 
								National New Drug Certificate and Production Certificate							
 | 
| 
								 Small Volume Injection Workshop of the Third Branch Passed New-vision GMP Gertification							
 | 
| 
								 China Top 100 Developing Enteprises							
 | 
| 
								SGS Audited Supplier							
 | 
| 
								Sales region							
 | 
| 
								Rated as Top Ten Enterprises in Hebei Province Pharmaceutical Industry 2013							
 | 
| 
								 New Version Company Video							
 | 
| 
								Talents are potential stocks for enterprise!							
 | 
| 
								CMO & Agency							
 | 
| 
								EU GMP Certificate of Dawn Pharma Issued Successfully							
 | 
| 
								Dawn Pharma's Two Injectable Lines Passed Site Inspection of EU GMP							
 | 
| 
								Paclitaxel for Injection (Albumin Bound)							
 | 
| 
								Doxorubicin HCl Liposome Injection 20mg 10ml							
 | 
| 
								Epirubicin HCl Injection 20mg/10ml							
 | 
| 
								Gemcitabine HCl for Injection 200mg; 1000mg							
 |